JONATHAN MCGEHEE: Open Payments
NPI 1386308211 · SPARTANBURG, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,497 in 84 payments from 14 companies in 2025. Trend: 2023 $164 · 2024 $1,814 · 2025 $1,497
Food & beverage: $1,497
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $351 |
| Janssen Biotech, Inc. | 15 | $234 |
| Novartis Pharmaceuticals Corporation | 10 | $185 |
| Amgen Inc. | 16 | $159 |
| UCB, Inc. | 8 | $137 |
| GlaxoSmithKline, LLC. | 4 | $117 |
| PFIZER INC. | 4 | $73 |
| Lilly USA, LLC | 3 | $63 |
| Organon LLC | 2 | $41 |
| Mallinckrodt Hospital Products Inc. | 1 | $34 |
Products named: TREMFYA, RINVOQ, COSENTYX, SKYRIZI, Bimzelx, BENLYSTA, XELJANZ, TALTZ.
Industry payments across SC — which companies pay providers there.
